Results 1 to 10 of about 53,072 (310)

The Impact of the AIDS Pandemic on Health Services in Africa: Evidence from Demographic and Health Surveys [PDF]

We document the impact of the AIDS crisis on non-AIDS related health services in fourteen sub-Saharan African countries. Using multiple waves of Demographic and Health Surveys (DHS) for each country, we examine antenatal care, birth deliveries, and rates
Anne Case, Christina Paxson
core  

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines

EBioMedicine, 2021
Youchun Wang
doaj   +1 more source

Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine

JCI Insight
Children with perinatally acquired HIV (PHIV) have special vaccination needs, as they make suboptimal immune responses. Here, we evaluated safety and immunogenicity of 2 doses of 4-component group B meningococcal vaccine in antiretroviral therapy–treated
Nicola Cotugno, Alessia Neri, Marco Sanna, Veronica Santilli, Emma Concetta Manno, Giuseppe Rubens Pascucci, Elena Morrocchi, Donato Amodio, Alessandra Ruggiero, Marta Luisa Ciofi degl Atti, Irene Barneschi, Silvia Grappi, Ilaria Cocchi, Vania Giacomet, Daria Trabattoni, Giulio Olivieri, Stefania Bernardi, Daniel O’Connor, Emanuele Montomoli, Andrew J. Pollard, Paolo Palma   +20 more
doaj   +1 more source

Innate protection against intrarectal SIV acquisition by a live SHIV vaccine

JCI Insight
Identifying immune correlates of protection is a major challenge in AIDS vaccine development. Anti-Envelope antibodies have been considered critical for protection against SIV/HIV (SHIV) acquisition.
Yongjun Sui, Thomas J. Meyer, Christine M. Fennessey, Brandon F. Keele, Kimia Dadkhah, Chi Ma, Celia C. LaBranche, Matthew W. Breed, Josh A. Kramer, Jianping Li, Savannah E. Howe, Guido Ferrari, LaTonya D. Williams, Maggie Cam, Michael C. Kelly, Xiaoying Shen, Georgia D. Tomaras, David Montefiori, Tim F. Greten, Christopher J. Miller, Jay A. Berzofsky   +20 more
doaj   +1 more source

AIDS Vaccines [PDF]

Nature Biotechnology, 1993
Sean Henahan, Gill Higgins
openaire   +2 more sources

Validation of a tool to assess knowledge about immunization among people living with HIV/AIDS. [PDF]

Rev Bras Enferm
Gerin L, Antonini M, Gir E, Reis RK.
europepmc   +1 more source

Prospects for an AIDS vaccine [PDF]

Clinical Medicine, 2003
openaire   +2 more sources

How Vaccinating People Living With HIV May Guide bNAb‑Based Vaccines. [PDF]

J Int AIDS Soc
Moore PL, Stamatatos L, Trkola A.
europepmc   +1 more source

Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines

In August 1997, the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) convened an expert working group to discuss current strategies for the development of HIV type 1 vaccines.
Honda, M., Lu, Y., Biberfeld, G., Jackson, A., Yamazaki, S., Bhamarapravati, N., Ferrari, G., Marchal, G., Falk, L. A., Esparza, J., Beddows, S., McKinney, J., Osmanov, S., Ballou, W. R., Aguado, M. T., Goldenthal, K. L., Hoft, D.   +16 more
core   +1 more source

Challenges facing long-acting PrEP implementation in large populations. [PDF]

Emerg Microbes Infect
Sun C, Liao Y.
europepmc   +1 more source